Skip to main content

Table 1 Demographic, clinical, and psychosocial characteristics of four groups of PLWH

From: Anxiety, depression, and sleep disturbances among people on long-term efavirenz-based treatment for HIV: a cross-sectional study in Beijing, China

Characteristics

Total

0.5 ≤ ART < 2 year

2 ≤ ART < 4 year

4 ≤ ART < 6 year

ART ≥ 6 year

P

(n=424)

(n=106)

(n=134)

(n=123)

(n=61)

Sex, n (%)

416 (98.1)

104 (98.1)

132 (98.5)

123 (100)

57 (93.4)

 

Age (years), median (IQR)

34 (30-40)

31 (27-36)

33 (30-39)

35 (31-39)

38 (33-47)

<0.001

Ethnicity, n (%)

398/42 (94.9)

100 (94.3)

125 (93.3)

114 (92.7)

59 (96.7)

0.775

Marital status, n (%)

     

0.058

Unmarried

313 (73.8)

313 (73.8)

79 (74.5)

97 (72.4)

101 (82.1)

 

Married

78 (18.4)

78 (18.4)

194 (17.9)

27 (20.1)

16 (13.0)

 

Divorced/separated /widowed

33 (7.8)

33 (7.8)

8 (7.5)

10 (7.5)

6 (4.9)

 

Education, n (%)

     

0.421

Postgraduate

55 (13.0)

13 (12.3)

16 (11.9)

20 (16.3)

6 (9.8)

 

College degree

191 (45.0)

48 (45.3)

58 (43.3)

60 (48.8)

25 (41.0)

 

Technical school graduate

72 (17.0)

14 (13.2)

24 (17.9)

23 (18.7)

11 (18.0)

 

below Technical school graduate

106 (25.0)

31 (29.2)

36 (26.9)

20 (16.3)

19 (31.1)

 

Employment type, n (%)

     

0.970

White-collar

127 (30.0)

31 (29.2)

39 (29.1)

40 (32.5)

17 (27.9)

 

Blue-collar

165 (38.9)

40 (37.7)

53 (39.6)

49 (39.8)

23 (37.7)

 

Student/unemployed /others

132 (31.1)

35 (33.0)

42 (31.3)

34 (27.6)

21 (34.4)

 

BMI (Kg/m2), median (IQR)

22.8 (20.8-24.7)

22.1 (20.1-24.6)

22.9 (20.8-25.0)

22.9 (20.8-25.0)

22.8 (20.3-24.2)

0.359

Sexual transmission route, n (%)

     

0.015

Homosexual

304 (71.7)

76 (71.7)

93 (69.4)

99 (80.5)

36 (59.0)

 

bisexual

39 (9.2)

6 (5.7)

13 (9.7)

10 (8.1)

10 (16.4)

 

Blood borne

9 (2.1)

3 (2.8)

2 (1.5)

0 (0)

4 (6.6)

 

others

72 (17.0)

21 (19.8)

26 (19.4)

14 (11.4)

11 (18.0)

 

Time on EFV-based ART (years), median (IQR)

3.4 (2.0,5.1)

1.6 (1.2,1.8)

2.9 (2.4,3.3)

4.8 (4.3,5.4)

7.7 (6.8,8.8)

<0.001

CD4+ T cells counts (cells/μl), median (IQR)

514 (413-722)

554 (341-652)

601 (401-713)

541 (466-748)

541 (431-708)

0.012

HIV-1 RNA (copies/ml)

<50

     
  1. Comparison among four groups was performed by one-way analysis of variance (ANOVA) or Kruskal-Wallis test. p < 0.05 was considered statistically significant
  2. EFV efavirenz, ART antiretroviral therapy, BMI Body Mass Index